Serviço de Endocrinologia e Metabologia do HCPA
Porto Alegre, Rio Grande do Sul, 90035-0033, Brazil
NCT Number: NCT03451201
To study the effect of 8 week high-intensity interval training (HIIT) compared with moderate intensity (MCT) interval training and sedentary patients(CON) with type 1 diabetes. Adult T1DM patients without known complications are randomised in blocks into these 3 groups according to their baseline flow mediated dilation (FMD). After 8 week exercise training, the main outcome, FMD, is re-evaluated. Additional variables such as VO2 peak for cardiovascular fitness, oxidative stress and endothelial independent vasodilation to study vascular rigidity are also evaluated.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Porto Alegre, Rio Grande do Sul, 90035-0033, Brazil
In a randomized controlled open trial, 36 adult type 1 diabetes mellitus (T1DM) patients without known complications were randomized into 3 groups: HIIT n=12; MCT n=12 and a sedentary control group (CON) n=12. Total sample size was calculated to a power of 80% alha 0.05 and a difference in mean FMD of 2%. Before randomisation, flow mediated dilation (FMD) and maximal exercise capacity (VO2 peak)is determined. Block Randomisation based on FMD rank values are done to equalize baseline FMD. Exercise sessions are performed in cycle ergometers during 40 minutes, 3 times a week, along 8 weeks. HIIT protocol, intensity vary from 50 to 85% of the maximum heart rate (HRmax), while in MCT, HR remained stable at 50% HRmax. Endothelial function was measured by flow mediated dilation (FMD) for endothelium-dependent vasodilation (EDVD) and smooth-muscle function was measured by nitroglycerine mediated dilation (endothelium independent vascular dilation) - (EIVD). Peak oxygen consumption (VO2peak) and oxidative stress markers were determined before and after the training period. ED was defined as an increase of less than 8% in vascular diameter after cuff release.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
T1DM
Exclusion criteria
High Intensity Interval Exercise Training in cycle ergometer, exercising at 80% of maximal capacity during one minute alternated with exercise at 50% of maximal capacity during 4 minutes intervals, for a total of 30 minutes. Three times a week for 8 weeks
Moderate Continuous Exercise Training 3 times a week for 8 weeks at 50% of maximal capacity
Conventional care for sedentary Type 1 Diabetes Controls. No intervention.
Time frame: 8 weeks
Percent of change from baseline in flow mediated dilation measured through arterial ultrasound at right arm
Time frame: 8 weeks
Percent of change in maximal oxygen capacity measured by in maximal oxygen consumption
Time frame: 8 weeks
Percent of change from baseline in nitrate mediated dilation measured through arterial ultrasound at right arm
Hospital de Clinicas de Porto Alegre
Other
Effect of High-Intensity Interval Exercise Training Compared With Moderate-intensity Continuous Training on Endothelial Function and Cardiorespiratory Fitness of Type 1 Diabetes Patients
Acronym: HIIT-T1D
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03859401
Autoimmune Diseases, Behavior
Charlottesville, Virginia, United States
View Trial DetailsNCT04926298
Autoimmune Diseases, Behavior
Brest, France
View Trial DetailsNCT03845114
Autoimmune Diseases, Behavior
Montreal, Quebec, Canada
View Trial DetailsNCT02558491
Autoimmune Diseases, Behavior
Charlottesville, Virginia, United States
View Trial Details